News

News
Share this article
22 January 2016

EU Lead Factory Early Career Researcher Event showcases novel ideas in Medicinal and Synthetic Chemistry in Barcelona, Spain

The European Lead Factory acknowledges the need for open exchange between researchers with different professional background and puts a focus on the career development of young scientists.

News
Share this article
21 December 2015

JECL sparks Drug Discovery community interest

Just one month after publication, the Drug Discovery Today article by Karawajczyk et al describing the quality of the JECL public compounds has reached Top 5 of the most downloaded articles of this prestigious journal.

News
Share this article
16 December 2015

The European Lead Factory has achieved significant milestones for 2015

400,000 novel drug-like compounds are now compiled in the Joint European Compound Library (JECL); and 60 drug targets have been selected for screening.

News
Share this article
16 December 2015

TI Pharma is now Lygature

Top Institute Pharma (TI Pharma), one of the partners in the EU Lead Factory, will be named Lygature as from January 1st 2016.

News
Share this article
14 December 2015

Award-winning HDB software published in Drug Discovery Today

The Honest Data Broker (HDB), a cloud-based informatics system, has been developed specifically to balance the intellectual property and scientific requirements of the consortium partners regarding the unique HTS screening and triage workflow within the EU Lead Factory.

News
Share this article
10 December 2015

The Netherlands Translational Research Center (NTRC) has identified IDO1 inhibitors with best-in-class properties

They have been developed from a series of inhibitor compounds first identified by screening the JECL of the European Lead Factory against IOD1 and TDO, important targets in cancer immunotherapy.

News
Share this article
09 December 2015

Patent filed for European Lead Factory compounds

Within 3 years after the launch of the European Lead Factory, the first patent protecting the outcomes of a drug target programme has been filed. The patent addresses multidrug resistance in bacterial infections. This important milestone reflects the EU Lead Factory’s ability to deliver on its promise, and highlights the potential of this shared-innovation approach to drug discovery.

News
Share this article
07 December 2015

Praise for the EU Lead Factory

Read the latest testimonial from a public drug target programme owner.

News
Share this article
30 October 2015

Early Career Researcher Event

EU Lead Factory welcomes PostDocs and PhDs.

News
Share this article
30 October 2015

Midterm Report: Reviewers acknowledge “highly significant achievements”

Independent reviewers acknowledged the achievements of EU Lead Factory as “highly significant” in the evaluation of the project’s midterm report.

Pages